Inhibition of BET bromodomain, epigenetic regulator, as an effective therapeutic approach for gastric cancer

被引：0
|
作者：
Kang, Sun Kyoung
Kim, Tae Soo
Kwon, Woo Sun
Roh, Jae Kyung
Lim, Ho-Yeong
Chun, Hyun Cheol
Rha, Sun Young
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-5069
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5069
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer
    Wyce, Anastasia
    Degenhardt, Yan
    Bai, Yuchen
    Le, BaoChau
    Korenchuk, Susan
    Crouthamel, Ming-Chih
    McHugh, Charles F.
    Vessella, Robert
    Creasy, Caretha L.
    Tummino, Peter J.
    Barbash, Olena
    ONCOTARGET, 2013, 4 (12) : 2419 - 2429
  • [2] Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer
    Wyce, Anastasia
    Degenhardt, Yan
    Bai, Yuchen
    Le, BaoChau
    Korenchuk, Susan
    Crouthamel, Ming-Chih
    McHugh, Charles F.
    Vessella, Robert
    Creasy, Caretha L.
    Tummino, Peter J.
    Barbash, Olena
    CANCER RESEARCH, 2014, 74 (19)
  • [3] Therapeutic resistance to BET bromodomain inhibition in prostate cancer
    Engelke, Carl G.
    Malik, Rohit
    Kregel, Steven
    Asangani, Irfan A.
    Wilder-Romans, Kari
    Jiang, Xia
    Cao, Xuhong
    Speers, Corey
    Chinnaiyan, Arul M.
    CANCER RESEARCH, 2017, 77
  • [4] Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancer
    Kang, Sun Kyoung
    Bae, Hyun Joo
    Kwon, Woo Sun
    Kim, Tae Soo
    Kim, Kyoo Hyun
    Park, Sejung
    Yu, Seo Young
    Hwang, Jihyun
    Park, Juin
    Chung, Hyun Cheol
    Rha, Sun Young
    CELLULAR ONCOLOGY, 2021, 44 (06) : 1387 - 1403
  • [5] Inhibition of BET bromodomain proteins as a therapeutic approach in small cell lung cancer
    Wyce, Anastasia
    Le, BaoChau
    Bai, Yuchen
    Soong, David
    Zhang, Xi-Ping
    Matteo, Jeanne J.
    Korenchuk, Susan
    Butticello, Michael F.
    Plant, Ramona
    Bleam, Maureen R.
    Degenhardt, Yan
    McHugh, Charles F.
    Carpenter, Christopher
    Tummino, Peter J.
    Barbash, Olena
    CANCER RESEARCH, 2015, 75
  • [6] Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancer
    Sun Kyoung Kang
    Hyun Joo Bae
    Woo Sun Kwon
    Tae Soo Kim
    Kyoo Hyun Kim
    Sejung Park
    Seo Young Yu
    Jihyun Hwang
    Juin Park
    Hyun Cheol Chung
    Sun Young Rha
    Cellular Oncology, 2021, 44 : 1387 - 1403
  • [7] Epigenetic heterogeneity promotes acquired resistance to BET bromodomain inhibition in ovarian cancer
    Sun, Yunheng
    Zhang, Zhenfeng
    Zhang, Ke
    Liu, Yuxia
    Shen, Peiye
    Cai, Meichun
    Jia, Chengiang
    Wang, Wenjing
    Gu, Zhuowei
    Ma, Pengfei
    Lu, Huaiwu
    Guan, Lei
    Di, Wen
    Zhuang, Guanglei
    Yin, Xia
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 3021 - +
  • [8] Selective BET bromodomain inhibition as an antifungal therapeutic strategy
    Mietton, Flore
    Ferri, Elena
    Champleboux, Morgane
    Zala, Ninon
    Maubon, Daniele
    Zhou, Yingsheng
    Harbut, Mike
    Spittler, Didier
    Garnaud, Cecile
    Courcon, Marie
    Chauvel, Murielle
    d'Enfert, Christophe
    Kashemirov, Boris A.
    Hull, Mitchell
    Cornet, Muriel
    McKenna, Charles E.
    Govin, Jerome
    Petosa, Carlo
    NATURE COMMUNICATIONS, 2017, 8
  • [9] The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
    Shi, Junwei
    Vakoc, Christopher R.
    MOLECULAR CELL, 2014, 54 (05) : 728 - 736
  • [10] Selective BET bromodomain inhibition as an antifungal therapeutic strategy
    Flore Mietton
    Elena Ferri
    Morgane Champleboux
    Ninon Zala
    Danièle Maubon
    Yingsheng Zhou
    Mike Harbut
    Didier Spittler
    Cécile Garnaud
    Marie Courçon
    Murielle Chauvel
    Christophe d’Enfert
    Boris A. Kashemirov
    Mitchell Hull
    Muriel Cornet
    Charles E. McKenna
    Jérôme Govin
    Carlo Petosa
    Nature Communications, 8
12345